Thu, Apr 25, 2024
[Archive]
Volume 1, Issue 1 (November 2016)
JNFS 2016, 1(1): 49-62 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shahvazi S, Nadjarzadeh A, Mehri Z, Salehi-Abargouei A. Prevalence of Metabolic Syndrome in Adult Females: Comparison between Iranian National Definition and Currently Used International Criteria. JNFS 2016; 1 (1) :49-62
URL: http://jnfs.ssu.ac.ir/article-1-22-en.html
URL: http://jnfs.ssu.ac.ir/article-1-22-en.html
Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract: (4116 Views)
Background: The prevalence of metabolic syndrome (MetS) is increasing worldwide. Limited data are available trying to compare different definitions suggested to identify MetS. This study aimed to compare the prevalence of MetS and its components based on currently available international and Iranian national definitions. Methods: The present cross-sectional study was conducted in 2015 amongfemale teachers residing in Yazd city. Demographic data and information on physical activity, participants, education, economic statusand number of deliveries were gathered using self-administered questionnaires. Anthropometric measurements and serum lipid profile were assessed according to standard procedures. MetS was defined based on international diabetes federation (IDF), national cholesterol education program; adult treatment panel III (NCEP, ATPIII), and Iranian national definition. Results: A total number of 450 participants aged 40.60 ± 8.25 y were included in this analysis. Prevalence of MetS based on ATPIII definition, IDF definition, and Iranian modified definition were 39.11%, 40.89%, and 31.11%, respectively. Prevalence of MetS among women aged over 50 y was more than those aged 20-50 y (P < 0.001). Based on different definitions, women with higher physical activity had lower prevalence of MetS (base on ATPIII, P = 0.036). Prevalence of MetS also was higher in women with more deliveries (for three definitions, P < 0.001). Conclusions: The prevalence of MetS was high in female teachers living in central province of Iran. It seems that ATPIII and Iranian national criteria can better represent the differences in the prevalence of MetS. Large scale prospective studies are recommended to confirm our results.
Type of article: orginal article |
Subject:
public specific
Received: 2016/05/8 | Published: 2016/08/27 | ePublished: 2016/08/27
Received: 2016/05/8 | Published: 2016/08/27 | ePublished: 2016/08/27
References
1. Ainsworth BE, et al. 2000. Compendium of physical activities: an update of activity codes and MET intensities. Medicine and science in sports and exercise.32(9; SUPP/1): S498-S504.
2. Al-Qahtani DA, Imtiaz ML, Saad OS & Hussein NM 2006. AComparison of the Prevalence of Metabolic Syndrome in Saudi Adult Females Using Two Definitions. Metabolic syndrome and related disorders.4(3): 204-214.
3. Alberti K, Zimmet P & Shaw J 2006. Metabolic syndrome—a new world‐wide definition. A consensus statement from the international diabetes federation. Diabetic medicine.23(5): 469-480.
4. Alberti KGMM & Zimmet Pf 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic medicine.15(7): 539-553.
5. Athyros VG, et al. 2011. Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. Arch Med Sci.7(5): 796-805.
6. Austin MA, King M-C, Bawol RD, Hulley SB & Friedman GD 1987. Risk Factors For Coronary Heart Disease In Adult Female Twins Genetic Heritability And Shared Environmental Influences. American Journal of Epidemiology.125(2): 308-318.
7. Azizi F, Salehi P, Etemadi A & Zahedi-Asl S 2003. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes research and clinical practice.61(1): 29-37.
8. Balkau B & Charles M-A 1999. Comment on the provisional report from the WHO consultation. Diabetic medicine.16(5): 442-443.
9. Barahimi H, Rajaii F & Esmaiilain R 2009. The prevalence of metabolic syndrome in women of reproductive age in Shar Reaz city- 2007. Journal of Diabetes and Metabolism.8(2): 177-184.
10. Beltrán-Sánchez H, Harhay MO, Harhay MM & McElligott S 2013. Prevalence and trends of metabolic syndrome in the adult US population, 1999–2010. Journal of the American College of Cardiology.62(8): 697-703.
11. Bucher K, et al. 1988. Biological and cultural sources of familial resemblance in plasma lipids: a comparison between North America and Israel—the Lipid Research Clinics Program. Genetic epidemiology.5(1): 17-33.
12. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A & Kelishadi R 2009. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East the National Survey of risk factors for noncommunicable diseases of Iran. Diabetes care.32(6): 1092-1097.
13. Einhorn M, FACP, FACE, Daniel 2003. American College of Endocrinology position statement on the insulin resistance syndrome*. Endocrine Practice.9(Supplement 2): 5-21.
14. Escobedo J, et al. 2009. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovascular diabetology.8(1): 52.
15. Esmailzadehha N, Ziaee A, Kazemifar A, Ghorbani A & Oveisi S 2013. Prevalence of metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran: A comparative analysis of six definitions. Endocr Regul.47: 111-120.
16. Esteghamati A, et al. 2009. Association between physical activity and insulin resistance in Iranian adults: National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Preventive medicine.49(5): 402-406.
17. Fakhrzadeh H, Ebrahimpour P, Pourebrahim R, Heshmat R & Larijani B 2006. Metabolic Syndrome and its Associated Risk Factors in Healthy Adults: APopulation-Based Study in Iran. Metabolic syndrome and related disorders. 4(1): 28-34.
18. Fereidoun Azizi M, et al. 2010. Appropriate Definition of Metabolic Syndrome among Iranian Adults: Report of the Iranian National Commit-tee of Obesity. Archives of Iranian medicine.13(5): 426.
19. Ghorbani R, et al. 2012. Prevalence of metabolic syndrome according to ATPIII and IDF criteria in the Iranian population. Koomesh.14(1): Pe65-Pe75, En10.
20. Grundy SM, et al. 2005. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation.112(17): 2735-2752.
21. Gu D, et al. 2005. Prevalence of the metabolic syndrome and overweight among adults in China. The Lancet.365(9468): 1398-1405.
22. Gundogan K, et al. 2013. Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Arch Med Sci.9(2): 243-253.
23. Hadaeqh F, Zabetiyan A & Azizi F 2007. The prevalence of the Metabolic Syndrome according the new IDF definition and its consistent with ATPIII and WHO definitions-Tehran Lipid and Glucose Study. Journal of Diabetes and Metabolism.6(4): 367-375.
24. Heller DA, de Faire U, Pedersen NL, Dahlen G & McClearn GE 1993. Genetic and environmental influences on serum lipid levels in twins. New England Journal of Medicine. 328(16): 1150-1156.
25. Hu G, et al. 2004. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Archives of internal medicine.164(10): 1066-1076.
26. Hui WS, Liu Z & Ho SC 2010. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. European journal of epidemiology.25(6): 375-384.
27. Iqbal Hydrie MZ, Shera AS, Fawwad A, Basit A & Hussain D Sc A 2009. Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria. Metabolic syndrome and related disorders.7(2): 119-124.
28. Jamali E, et al. 2014. Determinatin of direct and non direct costs in diabetic patients referred to Yazd Diabetes Research Center- 2013 Journal of clinical care.1(2): 34-43 (in Farsi).
29. Kaykhaei M, et al. 2012. Prevalence of metabolic syndrome in adult population from zahedan, southeast iran. Iranian journal of public health.41(2): 70.
30. Lim S, et al. 2011. Increasing prevalence of metabolic syndrome in Korea the Korean national health and nutrition examination survey for 1998–2007. Diabetes care.34(6): 1323-1328.
31. Marjani A, Hezarkhani S & Shahini N 2012. Prevalence of metabolic syndrome among fars ethnic women in North East of Iran. World Journal of Medical Sciences.7(1): 17-22.
32. Onat A, et al. 2002. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis.165(2):
33. 285-292.
34. Mirmiran p, Mohammadi F, Allahverdian S & Azizi F 2001. Measurement of total energy requirement in adults: prospective Tehran Lipid and Glucose Study. Pajouhandeh, J. Shaheed Beheshti Univ. Med. Sci. 6 (2001).6(22): 157-166 (in Farsi).
35. Pourhoseingholi MA, Vahedi M & Rahimzadeh M 2013. Sample size calculation in medical studies. Gastroenterology and hepatology from bed to bench.6(1): 14-17.
36. Program RotNCE 2001. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). National Institutes of Health.
37. Riediger ND & Clara I 2011. Prevalence of metabolic syndrome in the Canadian adult population. Canadian Medical Association Journal.183(15): E1127-E1134.
38. Sadrbafoghi S, et al. 2006. Prevalence and criteria of metabolic syndrome in an urban population: Yazd Healthy Heart Project. Tehran University Medical Journal.64(10): 90-96.
39. Seneff S, Wainwright G & Mascitelli L 2011. Review paper Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet? arch Med Sci.7(1): 8-20.
40. Sharma SK, et al. 2011. Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. International journal of hypertension.2011: 9.
41. Zabetian A, Hadaegh F & Azizi F 2007. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes research and clinical practice.77(2): 251-257.
42. Zhu S, St-Onge M-P, Heshka S & Heymsfield SB 2004. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism.53(11): 1503-1511.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
